Yehuda Poliker Reveals His Battle with Progressive Lung Disease Fibrosis

Yehuda Poliker, the renowned Israeli singer and musician, has publicly disclosed his struggle with pulmonary fibrosis, a chronic lung condition characterized by gradual scarring of lung tissue that impairs breathing. Ahead of his recent stage performance, Poliker was seen connected to an oxygen supply, highlighting the physical challenges posed by the disease. Despite this, he continues to perform, demonstrating a pragmatic acceptance of his condition, stating, "In the end, we all die of something."

Pulmonary fibrosis involves the thickening and stiffening of lung tissue, which reduces the lungs' ability to transfer oxygen into the bloodstream. This can lead to increased breathlessness and the need for supplemental oxygen, especially during physical exertion. Poliker's use of oxygen before performing underscores the significant respiratory effort required for activities such as singing and moving on stage. However, the exact type and severity of his fibrosis have not been publicly disclosed.

Symptoms often begin subtly, including shortness of breath during exertion, persistent dry cough, fatigue, and muscle or joint pain, which can be mistaken for normal aging or decreased fitness. As the disease progresses, even routine tasks may become difficult, and some patients experience clubbing of the fingers. Treatment focuses on slowing disease progression and managing symptoms, as existing lung scarring is irreversible. Recent advances include the European approval of a new drug, JASCAYD (active ingredient Nerandomilast), which has shown promise in slowing lung function decline in idiopathic pulmonary fibrosis and advanced cases.

Dr. Avraham Rami Unterman, a lung disease specialist at Ichilov Medical Center, hailed this medication as a significant breakthrough and hopes it will be included in Israel's national health basket by 2027. Poliker's openness about his condition brings awareness to the disease's impact and the importance of early diagnosis and treatment to preserve lung function. His statement and visible use of oxygen before performances vividly illustrate the complex reality of living with a serious lung disease while continuing a demanding artistic career.